Elevance Health, Inc.ELV

Market cap
$125.2B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Net Income----------6,0956,019
Net losses (gains) on financial instruments----------318-550
Equity in net earnings of other invested assets----------562293
Depreciation and amortization---------1,1541,3021,675
Deferred income taxes102745931-66127-1,2729181-540326-76
Impairment of property and equipment95-48824535-198737
Share-based compensation136135146169148165170226294283255264
Receivables, net-1104024181,900431,381226951,0532562,1382,510
Other invested assets591522-619361483270-11
Other assets32025934-405-3412862926170283-37-120
Policy liabilities-331978-3461,241193322732-1,0591,8263,5282,5972,254
Unearned income---------202-113-42
Accounts payable and other liabilities---------1,978719824
Income taxes-----179-194323-32572140-338
Other, net44143984597165205926-2166
Net cash provided by operating activities1,4173,3743,0523,3694,1163,2054,1853,8276,06110,6888,3648,399
Purchases of investments---------19,49218,66924,946
Proceeds from sale of investments---------11,31810,26911,988
Maturities, calls and redemptions from investments3,3221,8911,8371,3191,3141,4191,8481,9382,4374,7414,34410,620
Changes in securities lending collateral--29405546-214-222-624149-254849956301
Purchases of subsidiaries, net of cash acquired-0600--639-2,0801,760-1,9763,476649
Purchases of property and equipment4515206477156385848001,2081,0771,0211,0871,152
Other, net7631-1083-1271504563120
Net cash used in investing activities-1,271-942-2,234-975-1,151-514-5,082-1,259-2,792-7,324-9,638-4,560
Proceeds from (Repayments of) Commercial Paper-464-192-379682-53175-107-297-15050-300
Proceeds from long-term borrowings1,0891,0971,2502,7001,227-5,4588352,4732,4843,4623,071
Repayments of long-term borrowings4827051,8021,7302,697-2,8151,6841,1231,9321,0681,899
Proceeds from Short-Term Debt-1001,1002,0502,7602,4005,8359,1207,5909701,3251,365
Repayments of short-term borrowings-1009502,0502,6202,5005,0009,2508,0351,6701,0501,375
Changes in securities lending payable--29405546-214-222-624150-254849956302
Changes in bank overdrafts-2826410173-24451471-210-169--933
Repurchase and retirement of common stock4,3603,0401,6202,9991,516-1,9981,6851,7012,7001,9002,316
Cash dividends-3584484816576847057768189541,1041,229
Proceeds from Stock Options Exercised144245525301186119225173187176203182
Taxes paid through withholding of common stock under employee stock plans------47818412810293
Other, net---------488-34941
Net cash (used in) provided by financing activities-3,169-2,019-1,718-1,822-2,997-733427-2,241-2,266-2,567423-1,318
Effect of foreign exchange rates on cash and cash equivalents------------14
Change in cash and cash equivalents---------804-8612,507